Rodriguez-Torres, M <br/><br/>
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.  [electronic resource] 

 -  Journal of viral hepatitis  Feb 2010 
 - 139-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2893.2009.01157.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antiviral Agents--administration & dosage<br/>Body Mass Index<br/>Ethnicity<br/>Female<br/>Hepacivirus--isolation & purification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Prognosis<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--administration & dosage<br/>Treatment Outcome<br/>Viral Load